日媒：安斯泰来涉间谍案日籍员工预计12月中旬刑满获释、将被遣返回日本
东京 — 据共同社11月7日援引多名日中关系消息人士报道，因间谍罪在中国服刑的日本制药企业安斯泰来（Astellas Pharma）一名日籍男性员工，预计将于12月中旬刑满获释，并很可能在获释后立即被遣返回日本。
这名员工现年60多岁，在中国工作多年，曾任安斯泰来中国子公司高管与中国日本商会干部。他原定结束任期回国，于2023年3月在北京被中国有关部门拘留，2024年8月被起诉；北京市第二中级人民法院2025年7月以间谍罪判处他有期徒刑三年六个月。他的刑期计入被拘留期间，预计服满全部刑期。
判决作出后，日本内阁官房副长官曾表示判决「极其令人遗憾」，日本政府一直要求中方尽早放人。据路透社报道，安斯泰来、日本外务省与中国驻东京大使馆均未回应其置评请求。上述获释安排目前为日媒援引消息人士的说法，尚无中日官方确认。（来源：共同社）
Japanese Media: Astellas Employee Jailed in China for Espionage Expected to Be Released in Mid-December and Returned to Japan
Tokyo — A Japanese employee of Astellas Pharma imprisoned in China for espionage is expected to be released in mid-December after serving his full sentence and is likely to be deported to Japan immediately afterwards, Kyodo News reported on November 7, citing several sources close to Japan-China relations.
The man, in his 60s, worked in China for many years, serving as an executive at Astellas's Chinese unit and as a senior official of the Japanese Chamber of Commerce and Industry in China. He was detained in Beijing in March 2023, just before a scheduled return to Japan, and was indicted in August 2024. In July 2025, Beijing No. 2 Intermediate People's Court sentenced him to three years and six months in prison for espionage; the sentence includes the period he spent in detention before the ruling.
After the sentencing, Japan's deputy chief cabinet secretary called the ruling extremely regrettable, and the Japanese government has sought his early release. Reuters reported that Astellas Pharma, Japan's foreign ministry and the Chinese embassy in Tokyo did not respond to its requests for comment. The expected release rests on Japanese media reports citing unnamed sources and has not been officially confirmed by either government. (Source: Kyodo News)
来源：共同社
发布：GSM·美国（发布链接）
图片来源：图：位于日本东京的国会议事堂（资料图，本站档案图）。 / Photo: The National Diet Building in Tokyo, Japan (file photo, GSM archive).
GSM Global · 本篇英文版 English edition of this story
